Innoviva (INVA) Accounts Payables (2010 - 2026)
Innoviva (INVA) posted Accounts Payables of $4.02 million for Q2 2026, down 25.4% from $5.38 million a year earlier and down 38.4% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva's Accounts Payables came in at $4.97 million, up 132.9% from FY2024.
- Annual Accounts Payables shows a five-year compound annual growth rate of 137.3% (FY2020 to FY2025).
- In prior years, Innoviva's Accounts Payables was $2.13 million in FY2024 (-68.3%), $6.72 million in FY2023 (+128.5%), $2.94 million in FY2022 and $27,000 in FY2021 (-59.1%).
- The Q2 2026 figure stands as the lowest quarterly Accounts Payables since Q4 2024.
- On a year-over-year basis, Accounts Payables increased in five of the last seven quarters, with growth averaging 102.8%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2025, with growth of 428.1%; the weakest was Q3 2021, with a decline of 85.7%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $6.52 million (Q1 2026), $4.97 million (Q4 2025) and $6.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 4.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.02 Mn |
| Mar 31, 2026 | 6.52 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 890,000.00 |
| Dec 31, 2023 | 6.72 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 89,000.00 |
API Access
Innoviva Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();